Abstract
POSOLOGY: DRUG DEVELOPMENT IN PEDIATRICS

Dr. Virendra Kushwaha, Dr. Pooja Agrawal*, Dr. Nasreen Fatma Khan and Dr. Tanvi Azmi

ABSTRACT

Reluctance to enroll pediatric subjects in clinical trials has left gaps in information about the dosing, safety, and efficacy of medications. A pediatric population is a diverse group comprising different subgroups and liquids being the most preferred dosage form for children, especially of lower age. However, in the absence of suitable or labeled dosage forms, the use of unlicensed and off-label non-standard formulations that are devoid of relevant scientific data and hence pose a high risk to pediatric patients. The approach to pediatric drug dosing needs to be based on the physiological characteristics of the child and the pharmacokinetic parameters of the drug. This review summarises the current knowledge on developmental changes in absorption, distribution, metabolism, and excretion and combines this knowledge with in vivo and in vitro pharmacokinetic data that are currently available for the ultimate goal of providing infants and children with safe and effective drug therapy and will be made possible by specifically including them in clinical trials. Guidelines formed are intended to be used in clinical practice and to form a basis for more research. Also, the integration of these guidelines, and combining them with pharmacodynamic effects, should be considered and could form a basis for further study.

Keywords: Pediatric, dosage form, pharmacokinetic, pharmacodynamic.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: NOVEMBER ISSUE PUBLISHED

    NOVEMBER 2022 Issue has been successfully launched on 1 NOVEMBER 2022.

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 5.467 to 6.044, due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT